Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GS-0272 by Gilead Sciences for Rheumatoid Arthritis: Likelihood of Approval
GS-0272 is under clinical development by Gilead Sciences and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...
Data Insights
GS-0272 by Gilead Sciences for Systemic Lupus Erythematosus: Likelihood of Approval
GS-0272 is under clinical development by Gilead Sciences and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData,...